CareDx, Inc.
NASDAQCareDx heads into its August 4 earnings report carrying the imprint of a dramatic short squeeze — and a CEO who sold into it. The most striking development in the run-up is how aggressively short sellers have retreated. Short interest collapsed 30% in a single week, dropping from roughly 8.7 million shares to just under 5.5 million, and now represents 10.7% of the free float…
CDNA short interest plunges 30% in one week to 10.67% of float, as stock rallies 7.6% and insiders accelerate sales.
Snapshot as of 1 Aug 2026
CareDx heads into its August 4 earnings report carrying the imprint of a dramatic short squeeze — and a CEO who sold into it. The most striking development in the run-up is how aggressively short sellers have…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CDNA — free to start on ORTEX.
Sign up for free →Open CDNA on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live CDNA data →